Five things you should know about the UK NSC
How much do you know about the UK National Screening Committee?
Search results for about
About this blog
Screening identifies apparently healthy people who may be at increased risk of a disease or condition, enabling earlier treatment or informed decisions. National population screening programmes are implemented on the advice of the UK National Screening Committee (UK NSC), which makes independent, evidence-based recommendations to …
How to write about risk: working to produce better public information on screening
Posted by:
Nick Johnstone-Waddell, Posted on:
-
Categories:
General, UK National Screening Committee
An article to get you thinking about screening, and its balance of risks and benefits.
Graham excited by challenges facing the evolving UK NSC
Dr Graham Shortland OBE talks about his roles on the UK NSC as vice-chair and a paediatric specialist and the exciting challenges facing the committee.
Anneke helps the UK NSC navigate the complexities of genetics
Anneke helps the UK NSC navigate the complexities of clinical genetics evidence in screening when public expectations about the ability of genetics to predict ill health are running high.
Partnership board updated on progress with SMA screening evidence review
The UK NSC and its partners were updated on work to review the evidence for newborn screening for spinal muscular atrophy at the second meeting of the SMA in-service evaluation partnership board.
New UK NSC guidance explains how conflicts of interest can be mitigated
New UK NSC guidance explains how the committee decides if action is required to mitigate declared conflicts of interest by stakeholders and members.
English government endorses recommendation to screen newborns for tyrosinaemia
The English government has endorsed the UK National Screening Committee’s recommendation to add hereditary tyrosinaemia type 1 to the conditions screened for by the NHS Newborn Blood Spot Screening Programme.
SMA ISE clinical pathway expert sub-group meets for first time
SMA screening in-service evaluation clinical pathway group holds its first meeting.
Screening workstreams prominent in England Rare Diseases Action Plan
The UK National Screening Committee's (UK NSC's) work to improve the newborn screening evidence base features prominently in the England Rare Diseases Action Plan 2024.